1%
Indications
Pimecrolimus Cream
is indicated as second-line therapy for the short-term and non-continuous
chronic treatment of mild to moderate atopic dermatitis in
non-immunocompromised adults and children 2 years of age and older, who have
failed to respond adequately to other topical prescription treatments, or when
those treatments are not advisable.
Pimecrolimus Cream is not indicated for use in children less than 2 years of age.